Nichi-Iko Pharmaceutical Co., Ltd. reported consolidated earnings results for the second quarter of the fiscal Year ending March 31, 2021. For the quarter, the company reported revenue of ¥89,631 million against ¥91,519 million a year ago. Operating profit was ¥523 million against ¥3,777 million a year ago. Profit attributable to owners of parent was ¥146 million against ¥3,006 million a year ago. Profit before tax was ¥369 million against ¥4,544 million a year ago. profit was ¥114 million against ¥2,940 million a year ago. Basic earnings per share was ¥2.28 against ¥47.14 a year ago. Diluted earnings per share was ¥2.28 against ¥46.90 a year ago.